News for Enzon Pharmaceuticals, Inc. (ENZN)

The PEGylated proteins market size is anticipated to grow from USD 1.31 Billion in 2022 to USD 3.78 Billion in 10 years. The market ought to witness a...

Increasing funding and investments in healthcare is a key factor driving antifungal drugs market revenue growth...

Carl Icahn's 13F portfolio value increased from $21.75B to $22.03B, with the number of holdings rising from 16 to 17. Click here for a detailed discussion.

Carl Icahn’s 13F portfolio value increased from $21.23B to $21.75B this quarter. Click here to see an update on the portfolio's trades for Q4 2022.

/PRNewswire/ -- The antifungal drugs market size reached USD 13.81 Billion in 2021 and is expected to register a CAGR of 3.6% during the forecast period,...

Carl Icahn’s 13F portfolio value increased from $20.86B to $21.23B this quarter. Find out more about the ongoing analysis of the changes made to the portfolio on a quarterly basis.

Carl Icahn’s 13F portfolio value decreased from $21.87B to $20.86B this quarter. Click to see an update on Carl's holdings for Q2 2022.

Read Enzon Pharmaceuticals (OTCMKTS:ENZN) Shares Pass Above 200 Day Moving Average of $0.32 at ETF Daily News

Read Enzon Pharmaceuticals (OTCMKTS:ENZN) Stock Price Passes Above Two Hundred Day Moving Average of $0.32 at ETF Daily News

/PRNewswire/ -- The "Antisense & RNAi Therapeutics Global Market Report 2022: By Technology, By Route, By Indication" report has been added to...

Photo by Yiorgos Ntrahas on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc.Markets Group Inc. (OTCQX:OTCM), operator of the OTCQX®, OTCQB® and Pink® ...

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc.Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX®, OTCQB® and Pink® financial...